Praveen P. Tipirneni - Jan 13, 2023 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
President and CEO, Director
Signature
/s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
Stock symbol
MORF
Transactions as of
Jan 13, 2023
Transactions value $
-$123,338
Form type
4
Date filed
1/18/2023, 06:05 PM
Previous filing
Jan 19, 2022
Next filing
Apr 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise +12.5K +297.19% 16.7K Jan 14, 2023 Direct F1
transaction MORF Common Stock Sale -$123K -4.03K -24.11% $30.63 12.7K Jan 14, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Award $0 +177K $0.00 177K Jan 13, 2023 Common Stock 177K $31.72 Direct F3
transaction MORF Restricted Stock Unit Award $0 +118K $0.00 118K Jan 13, 2023 Common Stock 118K Direct F1, F4
transaction MORF Restricted Stock Unit Options Exercise $0 +12.5K +50% $0.00 37.5K Jan 14, 2023 Common Stock 12.5K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2 The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F3 The option vests as to 2.0833% of the total shares monthly, beginning February 13, 2023, with 100% of the total shares vested and exercisable on January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
F4 The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
F5 The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.